Skip to main content
. 2022 Jan 12;11(2):356. doi: 10.3390/jcm11020356
aPTT Activated partial thromboplastin time
BCT Blood-component therapy
CCA Conventional coagulation assay
CFT Clot formation time (ROTEM® parameter)
CRYO Cryoprecipitate
CT Clotting time (ROTEM® parameter)
DCR Damage control resuscitation
ECMO Extracorporeal membrane oxygenation
FFP Fresh frozen plasma
INR International normalized ratio
iTACTIC implementing Treatment Algorithms for the Correction of Trauma-Induced Coagulopathy (clinical trial)
K Clot formation time
LI30 Lysis index at 30 min (ROTEM® parameter)
LY30 Lysis at 30 min (TEG® parameter)
MA Maximum amplitude (TEG® parameter)
MCF Maximum clot firmness (ROTEM® parameter)
ML Maximum lysis
MT Massive transfusion
NATO North Atlantic Treaty Organization
POC Point-of-care
PPOWER Pragmatic, Prehospital, Type O, Whole Blood Early Resuscitation (clinical trial)
PROPPER Pragmatic Randomized Optimal Platelet and Plasma Ratios (clinical trial)
PT Prothrombin time
R Reaction time (TEG® parameter)
RBC Red blood cells
ROTEM® Rotational thromboelastometry®
r-TEG® Rapid-thromboelastography®
STORHM Sang Total dans les Hémorragies Massives (clinical trial)
SWAT Shock Whole blood and Assessment of TBI (clinical trial)
TEG® Thromboelastography®
THOR Network Trauma Hemostasis and Oxygenation Research Network
TIC Trauma-induced coagulopathy
TOWAR Type O Whole Blood and Assessment of Age During Prehospital Resuscitation (clinical trial)
VHA Viscoelastic hemostatic assay
WB Whole blood
α-angle Alpha angle